Dr. Harry Menon, DO, MPH

Dr. Menon practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Dr. Menon's NPI, 1265826390, was assigned on March 26, 2015. Dr. Menon graduated from LECOM at Seton Hill - Greensburg in 2015. Dr. Menon holds Nevada license DO2896.

Dr. Menon's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Dr. Menon's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Dr. Menon is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Dr. Menon to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menon practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Menon's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Menon is board certified in hematology by the American Board of Internal Medicine. Dr. Menon is licensed in Nevada.

Dmand AI lists chronic anemia, chronic indigestion, contact dermatitis, enlarged prostate, fibromyalgia and chronic pain, purpura and thrombocytopenia and tobacco use among the conditions Dr. Menon treats.

CMS data shows 826 Medicare services from Dr. Menon across 6 procedure codes in 2024, for 297 Medicare patients. Medicare paid $60,805 for them.

CMS counts 297 Medicare patients who saw Dr. Menon in 2024. The largest group is 65 to 74, with 148 patients. 66% of them have high cholesterol, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Menon's median patient age at 72, with 44% women.

In 2024, Dr. Menon wrote 1,578 Medicare Part D claims for 213 patients. 77% of them were for generic drugs. CMS names the drug for 1,343 of them, across 39 drugs with 11 or more claims each, at $3,560,560 in total drug cost. In 2023, CMS named 839 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Menon for performance year 2024, reported as part of a group. Dr. Menon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Menon as offering telehealth.

Dmand AI links 4 papers to Dr. Menon, published from 2018 to 2021. 2021 was the busiest year, with 2. Dr. Menon's most frequent co-authors are Nelson Shu-Sang Yee, MD, Suhail M. Ali, MD and Tomasz M. Beer, MD.

CMS Open Payments shows 214 general payments to Dr. Menon from 39 drug and device companies from 2021 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. AstraZeneca Pharmaceuticals LP paid the most, $52,597.

Dr. Menon graduated from LECOM at Seton Hill - Greensburg in 2015. Dr. Menon is a member of ASCO.

Dr. Menon is in network with 9 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.